Eli Lilly signs a multi-billion dollar deal with AI drug developer Insilico Medicine.

The $2.75 billion partnership shows the pharmaceutical industry's high expectations for AI-driven drug discovery. AI aims to accelerate the lengthy and expensive development process.

AI-generated: summaries written by AI from the linked sources. How we use AI